Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Vermij, L.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(9)
+
-
Availability
Open access
(9)
+
-
Creation Date
2020
(2)
+
-
2021
(2)
+
-
2022
(2)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Scholarly Publications
(2)
+
-
Author
Vermij, L.
(9)
+
-
Bosse, T.
(8)
+
-
Horeweg, N.
(7)
+
-
Creutzberg, C.L.
(6)
+
-
Leary, A.
(5)
+
-
Leon-Castillo, A.
(5)
+
-
Powell, M.E.
(5)
+
-
Singh, N.
(5)
+
-
Boer, S.M. de
(4)
+
-
Crosbie, E.J.
(4)
+
-
Nout, R.A.
(4)
+
-
Smit, V.T.H.B.M.
(4)
+
-
Jobsen, J.J.
(3)
+
-
Mileshkin, L.R.
(3)
+
-
Nijman, H.W.
(3)
+
-
Smit, V.
(3)
+
-
Carlson, J.
(2)
+
-
Genestie, C.
(2)
+
-
Jurgenliemk-Schulz, I.M.
(2)
+
-
Khaw, P.
(2)
+
-
Mackay, H.J.
(2)
+
-
Oosting, J.
(2)
+
-
Rutten, T.A.
(2)
+
-
TransPORTEC Consortium
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
p53 immunohistochemistry in endometrial cancer
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
Prevalence and prognosis of Lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer
Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer
HER2 status in high-risk endometrial cancers (PORTEC-3)
Incorporation of molecular characteristics into endometrial cancer management
ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy